Stories
Successful bioequivalence studies for Bempedoic Acid and Bempedoic Acid + Ezetimibe in US
Synthon successfully completes bioequivalence studies for Bempedoic Acid and Bempedoic Acid + Ezetimibe in US.
read more
Synthon announces successful bioequivalence studies for Bempedoic acid
Synthon is proud to announce the completion of two successful bioequivalence (BE) studies for Bempedoic acid, a product we are developing for our…
read more
Synthon at DCAT Week 2023 in New York
We are thrilled to meet our business partners, industry colleagues and friends at DCAT Week in New York City from March 20-23, 2023.
read more
Synthon donates to Amalia Children's Hospital
Synthon donates a financial gift and materials to Amalia Children's Hospital.
read more
Synthon and SAJA sign agreement to commercialize a basket of products
Synthon is pleased to announce that it has entered into a partnership with Saudi-based SAJA, to commercialize several products in KSA and GCC region.
read more
We are attending CPHI 2022
You will be able to find us at the the upcoming international pharma event from CPHI Worldwide 2022 in Frankfurt, Germany.
read more
Support Team Wikke
Our colleague Liselijn Wisman is raising funds during de Nijmeegse Vierdaagse for the Oogfonds. Her son Wikke has the rare Leber's disease.
read more
Synthon Hispania certified by Top Employers Institute 2022
The Top Employer Institute certified Synthon Hispania as a reference company: one of the organizations with the best conditions for their employees…
read more
New Chief Commercial Officer
John McCullough has been appointed as Chief Commercial Officer.
read more
Synthon anniversary: 30 years of science, people and affordable medicines
17th of September 2021 marks a very special day in the history of Synthon. For 30 years we have been putting great science to work to bring affordable…
read more